PROM1 and glioblastoma: Compared with high levels of CD133+/CD15− cells in a childhood GBM xenograft tumor included as positive control (Figure 2A), only low levels (0.46 ± 0.57%) of CD133+/CD15− PLGG cells were detected in 22 tumors (Figure 2B).